Drug delivery by contact lens in spontaneously glaucomatous dogs

Current Eye Research

Volumn 37, Issue 3, 2012, Pages 204-211

  Peng, Cheng Chun ^a   Ben Shlomo, Anna ^b   MacKay, Edward O ^b   Plummer, Caryn E ^b   Chauhan, Anuj ^a  

^a University of Florida   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

Author keywords

Beagle dogs; Bioavailability; Contact lenses; Extended drug delivery; Glaucoma; IOP; Timolol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; EYE DROPS; PHOSPHATE BUFFERED SALINE; SILICON; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT LENS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; EXPERIMENTAL DOG; GLAUCOMA; HYDROGEL; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; PUPIL; TREATMENT RESPONSE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL AVAILABILITY; CONTACT LENSES, HYDROPHILIC; DISEASE MODELS, ANIMAL; DOGS; DRUG DELIVERY SYSTEMS; GLAUCOMA; INTRAOCULAR PRESSURE; OPHTHALMIC SOLUTIONS; TIMOLOL; VITAMIN E;

EID: 84857378874     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.630154     Document Type: Article

References (33)

1. Lang JC. Ocular drug-delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39-43.
2. Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res. 1998;17:33-58.
3. McNamara NA, Polse KA, Brand RJ, Graham AD, Chan JS, McKenney CD. Tear mixing under a soft contact lens: Effects of lens diameter. Am J Ophthalmol. 1999;127:659-665.
4. Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13:144-151.
5. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
6. Friedman DS, Nordstrom B, Mozaffari E, Quigley HA. Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology. 2005;112:1500-1504.
7. Hermann MM, Bron AM, Creuzot-Garcher CP, Diestelhorst M. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring. J Glaucoma. 2011;20:502-508.
8. Creech JL, Chauhan A, Radke CJ. Dispersive mixing in the posterior tear film under a soft contact lens. Ind Eng Chem Res. 2001;40:3015-3026.
9. Li CC, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind Eng Chem Re. 2006;45:3718-3734.
10. Karlgard CC, Wong NS, Jones LW, Moresoli C. In vitro uptake and release studies of ocular pharmaceutical agents by silicon- containing and p-HEMA hydrogel contact lens materials. Int J Pharm. 2003;257:141-151.
11. Kim J, Peng CC, Chauhan A. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. J Control Release. 2010;148:110-116.
12. Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials. 2010;31:4032-4047.
13. Zimmerman TJ, Boger WP 3rd. The β-adrenergic blocking agents and the treatment of glaucoma. Surv Ophthalmol. 1979;23:347-362.
14. Fraunfelder FT, Meyer SM. Systemic side effects from ophthalmic timolol and their prevention. J Ocul Pharmacol.1987;3:177-184.
15. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
16. Gelatt KN. Animal models for glaucoma. Invest Ophthalmol Vis Sci. 1977;16:592-596.
17. Gelatt KN, Mackay EO. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Vet Ophthalmol. 2001;4:283-288.
18. Gelatt KN, Mackay EO. Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Vet Ophthalmol. 2004;7:53-57.
19. Gelatt KN, Mackay EO, Dashiell T, Biken A. Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle. J Ocul Pharmacol Ther. 2004;20:411-420.
20. Gwin RM, Gelatt KN, Gum GG, Peiffer RL Jr, Williams LW. The effect of topical pilocarpine on intraocular pressure and pupil size in the normotensive and glaucomatous beagle. Invest Ophthalmol Vis Sci. 1977;16:1143-1148.
21. Plummer CE, Mackay EO, Gelatt KN. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs. Vet Ophthalmol. 2006;9:245-249.
22. Takiyama N, Shoji S, Habata I, Ohba S. The effects of a timolol maleate gel-forming solution on normotensive beagle dogs. J Vet Med Sci. 2006;68:631-633.
23. Volopich S, Mosing M, Auer U, Nell B. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma. Vet Ophthalmol. 2006;9:239-244.
24. Gelatt KN, Peiffer RL Jr, Gwin RM, Sauk JJ Jr. Glaucoma in the beagle. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81:636-644.
25. Bobik A, Jennings GL, Ashley P, Korner PI. Timolol pharmacokinetics and effects on heart rate and blood pressure after acute and chronic administration. Eur J Clin Pharm. 1979;16:243-249.
26. Tocco DJ, Duncan AE, Delauna FA, Hucker HB, Gruber VF, Vandenheuvel WJ. Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Dispos. 1975;3:361-370.
27. Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF. Timolol and atenolol: Relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics. Br J Clin Pharmacol. 1985;19:329-333.
28. Hillman JS. Management of acute glaucoma with pilocarpinesoaked hydrophilic lens. Br J Ophthalmol. 1974;58:674-679.
29. Hillman JS, Marsters JB, Broad A. Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma. Trans Ophthalmol Soc U K. 1975;95:79-84.
30. Ruben M, Watkins R. Pilocarpine dispensation for the soft hydrophilic contact lens. Br J Ophthalmol. 1975;59:455-458.
31. Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials. 2005;26:1293-1298.
32. Wilkie DA, Latimer CA. Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs. Am J Vet Res. 1991;52:432-435.
33. Zimmerman TJ, Kaufman HE. Timolol, dose response and duration of action. Arch Ophthalmol. 1977;95:605-607.